Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case–control study
Authors:
- 1 December 2015
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 139, 66-69
Abstract
No abstract availableKeywords
Funding Information
- Brain Aneurysm Foundation
This publication has 13 references indexed in Scilit:
- Guidelines for the Management of Aneurysmal Subarachnoid HemorrhageStroke, 2012
- ε-Aminocaproic Acid in Angiographically Negative Subarachnoid Hemorrhage Patients Is Safe: A Retrospective Review of 83 Consecutive PatientsNeurosurgery, 2011
- Short-Term Antifibrinolytic Therapy Before Early Aneurysm Treatment in Subarachnoid Hemorrhage: Effects on Rehemorrhage, Cerebral Ischemia, and HydrocephalusNeurosurgery, 2010
- Incidence of deep venous thrombosis after subarachnoid hemorrhageJournal of Neurosurgery, 2009
- Impact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid HemorrhageStroke, 2008
- Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized studyJournal of Neurosurgery, 2002
- Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapyJournal of Neurosurgery, 1997
- Incidence of Subarachnoid HemorrhageStroke, 1996
- Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage.Stroke, 1989
- Rerupture of intracranial aneurysms: a clinicoanatomic studyJournal of Neurosurgery, 1987